Content related to any stage of the drug life cycle-discovery, development and trials.
The health care market today is suffering a great loss because of the patient’s addiction to the opioids. Opioids are compounds which have psychological impact similar to that of the opium. Once habituated, it can be very difficult to get rid of it. According to study, one out four patients who receive opioids from the […]
In their quest to meet patient need and demand for chronic pain relief, American doctors are often forced by consumer demands and practice challenges to prescribe and over prescribe narcotic painkillers. Their training and experience have not focused on alternative treatment options, until now. Drug-Dangers in Dosages According to a National Safety Council (NSC) 2016 […]
The strife to fight antibiotic-resistant bacterial disease has been both incessant and intrepid. But with the advent of a new tool engineered by nanotechnology and the usage of light, has facilitated certain possibilities of bringing this strife to a culmination. Apart from the worldwide endeavours to pre-empt and suppress the overuse of antibiotic drugs, the […]
Up until now, photodynamic therapies have heavily relied on the content of O2 prevalent within the tissue. This, however, is rendered useless in the case of malignant and burgeoning tumours. Thus, a research team from Karlsruher Institut Fur Technologie (KIT) situated in Keiv, has contrived a photoswitchable molecule in order to supplement the method of […]
Drug delivery companies and the products borne from them are often characterised by complex partnerships between companies, with licensing agreements and strategic relationships. The challenges they seek to face and overcome rely upon strong technology delivering drugs to targeted sites in the patient. Outsourcing of opportunities has dramatically increased over the last decade. As a […]
Traditional way of drug making has extensively outdated. While many manufacturers have adapted efficient methods in manufacturing, but still a sizeable pharmaceutical companies work on an outmoded approach that is highly lethargic, inflexible, and prone to frequent breakdowns. A new invention of refrigerator-sized apparatus that can intake a set of ingredients and quickly able to produce four […]
The historical approach to clinical drug development, and one that served drug companies well for the past thirty years, was to initiate testing in humans at clinical research units, typically located in the UK and the US and to proceed further to Phase II testing and beyond to patients with clinical evidence of the disease […]
The incidence of Central Nervous System (CNS) illness is on the upswing and exacts a heavy human and economic toll. According to the World Health Organization, more than 120 million people worldwide suffer from depression, and the number is expected to rise. The occurrence of Alzheimer’s disease is slated to grow by more than 100 […]
Over the past decade there has been increasing pressure on the pharmaceutical industry to increase economic efficiencies in drug discovery. This has been driven by several factors including the increased costs of R&D, lower productivity, patent expiration, generic competition and the increasing difficulty in bringing new chemical entities to market. The extraordinary investment requirements have […]
Edward Jenner’s work in developing the world’s first smallpox vaccine in the 1790s demonstrated that it was possible to protect the general population from major threats to public health, and vaccine development aimed at combating the major concerns of the day has continued ever since. There have been many successes, and vaccines are now available […]